JNJ
Johnson & Johnson · BMV:JNJ
5,167.40 MXN−20.83 −0.40%
Johnson & Johnson (BMV:JNJ) last traded at 5,167.40 MXN, down 0.40% on the day. Over the past year the stock is up 48.93%. Its 52-week range is 3,410.01 to 5,240.79. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open5,240.79
Day range5,167.40 – 5,240.79
52-week range3,410.01 – 5,240.79
Volume349
Average volume (10 days)713
Market cap (USD)657.68 B
P/E43.34
EPS (TTM) (USD)6.59
Dividend yield1.93%
Beta (1 year)−0.1504
Revenue (TTM) (USD)99.35 B
Employees140.80 K
Performance
+5.05%1 week
+7.26%1 month
+16.12%3 months
+29.18%6 months
+38.02%Year to date
+48.93%1 year
Technical reading
Bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Johnson & Johnson reports 94% success rate in trial of coronary artery deviceSeeking Alpha · 01 Nov 2026
- Johnson & Johnson reports lower mortality rates with Impella heart pumpsSeeking Alpha · 01 Nov 2026
- J&J Reports Positive Survival And Outcomes With Impella In HrpciReuters · 01 Nov 2026
- Data Show Positive Survival and Patient Outcomes with Best-Practice Impella Support in HRPCI, in Contrast to CHIP-BCIS3 Study ResultsBusinessWire · 01 Nov 2026
- Ayushman Bharat Digital Mission Can Transform Healthcare Through Data, Says NITI Aayog MemberBusinessworld · 01 Nov 2026
- JNJ's MedTech Segment Disappoints in Q3: Will Growth Rebound in Q4?Zacks · 30 Oct 2026
- Experts red-flag cancer drug price cuts as patented therapies see zero relief, markups exceed benchmarkMint · 29 Oct 2026
- Over 100 of the 600-plus medicines listed by NPPA do not show a drop in pricesBusiness Line · 29 Oct 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.